The Organizing Committee require that authors submit their abstracts electronically via this website. To submit an abstract, an APPLICATION must first be submitted. You may submit an application online via this website. If you indicated on the application form that you intend to submit an abstract, you will receive an email notification containing a secure USERNAME and PASSWORD, which will grant you access to the ABSTRACT SUBMISSION page.

To submit an abstract, please have your USERNAME and PASSWORD available, click on the SUBMIT ABSTRACT button at the bottom of the page (Deadline has passed) and follow the step-by-step directions, which will enable you to upload the file containing your abstract from the computer system that you are using to access this website. To ensure your abstract retains any special characters or formatting, the abstract must be in MICROSOFT WORD or RTF format.

Multiple submissions from the same data set will jeopardize abstract acceptance. The Organizing Committee urges submission of a single abstract from the entire group involved in the study.

Each applicant may submit a MAXIMUM of two (2) abstracts. If more than two (2) abstracts are submitted, only the first 2 submissions will be evaluated.

The deadline for abstract submission is Friday, May 10, 2002.

Notifications of acceptance and format of presentation (oral or poster presentation) will be sent by June 3, 2002. Guidelines for preparing your poster presentations will be sent if your abstract is accepted.

Abstract presenters MAY NOT be changed after acceptance, without consent of the Organizing Committee.

SAMPLE ABSTRACT

To view a sample abstract, click here. The sample form is an Adobe Acrobat document. If your computer cannot read the sample, please click here to download Adobe's free Acrobat Reader.

ABSTRACT GUIDELINES

Format

Abstract submissions should not exceed 450 words. Clearly define all concepts and abbreviations at first use. If English is not your primary language, attempt to have your abstract reviewed by a native English speaker.

To be acceptable, abstracts shall contain a concise statement of the research. It is recommended that the author follow the structured format below:

Title
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).

Authors
Authors' names should be entered using intial(s) for the first and middle names followed by the full last name, with presenting author underlined (e.g. PM Coker, J Ballard, and AP Deutsch).

Affiliations
All affiliations should follow the last author's name and be referenced with superscript numbers. Each author should be listed by institution, city, and state (2 letter postal abbreviation) or country.

Background
State the problem under investigation or a hypothesis.

Methods
Explain the experimental methods used.

Results
List the essential results obtained in summary form, with enough quantitative data to permit evaluation by reviewers.

Conclusion
Summarize the findings. It is unacceptable to use statements such as "the results will be discussed".

ADDITIONAL ABSTRACT INFORMATION

In addition to the uploaded abstract, the following additional information will be collected:

Presenting Author Contact Information
The presenting author must enter a complete address to ensure that correspondence arrives promptly and easily.

Abstract Category
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Organizing Committee reserves the right to reassign your abstract to a more appropriate category.

• Resistance to New Antiretroviral Agents
• Mechanisms of HIV Drug Resistance
• HIV Pathogenesis, Fitness and Resistance
• Clinical Implications of Resistance
• Epidemiology
• New Resistance Technologies and Interpretations

PUBLISHED ABSTRACT BOOK

Accepted abstracts will be standardized in font and presentation. Abstracts will NOT be edited in any way. Thus, any error that appears in the submitted abstract will appear in the printed abstract.
Subject to availability, copies of the Abstracts on CD and the Abstract Book will be available for sale after the Conference:

Informed Horizons, LLC
1860 Montreal Road, Suite 212
Tucker GA 30084
USA
Tel: +1 770 946 3480
Fax: +1 770 897 9639